Innate immune system gene polymorphisms in women with vulvovaginal infections

Current Infectious Disease Reports

Volumn 6, Issue 6, 2004, Pages 462-468

  Genç, Mehmet R ^a   Onderdonk, Andrew ^b   Witkin, Steven S ^b  

^a Jinemed Medical Center   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MANNOSE BINDING LECTIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN RECOGNITION; CHLAMYDIA TRACHOMATIS; DEMOGRAPHY; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; ETHNIC GROUP; FEMALE; FEMALE GENITAL TRACT INFECTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; IMMUNE SYSTEM; NEISSERIA GONORRHOEAE; NONHUMAN; RACE DIFFERENCE; REVIEW; VULVOVAGINITIS;

EID: 10244245451     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0066-6     Document Type: Review

References (54)

1. Genç MR, Witkin SS, Delaney ML, et al.: A disproportionate increase in IL-b over IL-1ra in the cervicovaginal secretions of pregnant women with vaginal infection correlates with preterm birth. Am J Obstet Gynecol 2004, 190:1191-1197.
2. Rasmussen SJ, Eckmann L, Quayle AJ, et al.: Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997, 99:77-87
3. Fichorova RN, Desai PJ, Gibson FC, Genco CA: Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun 2001, 69:5840-5848.
4. Romero R, Mazor M, Brandt F, et al.: Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992, 27:117-123.
5. Romero R, Sepulveda W, Mazor M, et al.: The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992, 167:863-872.
6. Leslie KK, Lee SL, Woodcock SM, et al.: Acute intrauterine infection results in an imbalance between pro- and antiinflammatory cytokines in the pregnant rabbit. Am J Reprod Immunol 2000, 43:305-311.
7. Romero R, Tartakovsky B: The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice. Am J Obstet Gynecol 1992, 167:1041-1045.
8. Witkin S, Gravett M, Haluska G, Novy M: Induction of interleukin-1 receptor antagonist in rhesus monkeys after intraamniotic infection with group B streptococci or interleukin-1 infusion. Am J Obstet Gynecol 1994, 171:1668-1672.
9. Hurme M, Lahdenpohja N, Santtila S: Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998, 30:469-473.
10. Nguyen DP, Genc M, Vardhana S, et al.: Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol 2004, 104:293-300.
11. Danis VA, Millington M, Hyland VJ, Grennan D: Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995, 99:303-310.
12. Vamvakopoulos J, Green C, Metcalfe S: Genetic control of IL-1beta bioactivity through differential regulation of the IL,1 receptor antagonist. Eur J Immunol 2002, 32:2988-2996.
13. Hurme M, Santtila S: IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998, 28:2598-2602.
14. Tountas NA, Casini-Raggi V, Yang H: Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999, 117:806-813.
15. Andus T, Daig R, Vogl D, et al.: Imbalance of the interleukin 1 system in colonic mucosa: association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 1997, 41:651-657.
16. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998, 47:195-198.
17. El-Omar EM, Carrington M, Chow W-H, et al.: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
18. Hall SK, Perregaux DG, Gabel CA, et al.: Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004, 50:1976-1983.
19. Genç MR, Onderdonk AB, Vardhana S, et al.: Polymorphism in intron 2 of interleukin 1 receptor antagonist gene, abnormal vaginal microflora in midtrimester and preterm delivery. Am J Obstet Gynecol 2004, In press.
20. Barton PT, Gerber S, Skupski DW, Witkin SS: Interleukin-1 receptor antagonist gene polymorphism, vaginal interleukin-1 receptor antagonist concentrations, and vaginal Ureaplasma urealyticum colonization in pregnant women. Infect Immun 2003, 71: 71-274.
21. Foster DC, Hasday JD: Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997, 89:291-296.
22. Jeremias J, Ledger W, Witkin SS: Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 1999, 182:283-285.
23. Hajeer A, Hutchinson I: TNF-alpha gene polymorphism: clinical and biological implications. Micros Res Tech 2000, 50:216-228.
24. Prebeck S, Brade H, Kirschning CJ, et al.: The Gram-negative bacterium Chlamydia trachomatis L2 stimulates tumor necrosis factor secretion by innate immune cells independently of its endotoxin. Microbes Infect 2003, 5:463-470.
25. Zariffard MR, Harwani S, Novak RM, et al.: Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin Immunol 2004, 111:103-107.
26. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, et al.: High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. Infect Dis 2000, 182:467-473.
27. Imseis HM, Greig PC, Livengood CH, et al.: Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. Soc Gynecol Investig 1997, 4:90-94.
28. Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, Rosen P: IL-1beta, IL-6, TNF alpha, fetal fibronectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Obstet Gynecol Scand 1998, 77:701-706.
29. Taha TE, Hoover DR, Dallabetta GA, et al.: Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998, 12:1699-1706.
30. Martin HL, Richardson BA, Nyange PM, et al.: Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999, 180:1863-1868.
31. Clerici M, Merola M, Ferrario E, et al.: Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997, 89:245-250.
32. Tartour E, Gey A, Sastsre-Garou X, et al.: Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998, 90:287-294.
33. Tartour E, Pannetier C, Mathiot C, et al.: Prognostic value of cytokine and Fc gamma receptor assays in oncology. Immunol Lett 1995, 44:145-148.
34. Kirkpatrick A, Bidwell J, van den Brule AJ, et al.: TNF alpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 2004, 92:675-679.
35. Abreu MT, Arditi M: Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 2004, 144:421-429.
36. Arbour NC, Lorenz E, Schutte BC, et al.: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000, 25:187-191.
37. Schwartz DA: The genetics of innate immunity. Chest 002, 121:62S-68S.
38. Erridge C, Stewart J, Poxton IR: Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 2003, 197:1787-1791.
39. Genc MR, Vardhana S, Onderdonk A, et al.: Relationship between a toll-like receptor-4 gene polymorphism and cytokine response to vaginal microorganisms in pregnant women. Eur J Obstet Gynecol Reprod Biol 2004, 116:152-156.
40. Fichorova RN, Cronin AO, Lien E, et al.: Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol 2002, 168:2424-2432.
41. Darville T, O'Neill JM, Andrews CW Jr, et al.: Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 2003, 171:6187-6197.
42. Netea MG, Van Der Graaf CA, Vonk AG, et al.: The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002, 185: 483-1489.
43. Morre SA, Murillo LS, Bruggeman CA, Pena AS: The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility. J Infect Dis 2003, 187:341-342.
44. Morre SA, Murillo LS, Spaargaren J, et al.: Role of the toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J Infect Dis 2002, 186: 377-1379.
45. Babovic-Vuksanovic D, Snow K, Ten RM: Mannose-binding lectin (MBL) deficiency. Variant alleles in a Midwestern population of the United States. Ann Allergy Asthma Immunol 1999, 82: 34-143.
46. Babula O, Lazdane G, Kroica J, et al.: Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis 2003, 37:733-737.
47. Wu C: Heat shock transcription factors: structure and regulation. Annu Rev Cell Dev Biol 1995, 11:441-469.
48. Cahill CM, Waterman WR, Xie Y, et al.: Transcriptional repression of the prointerleukin 1beta gene by heat shock factor 1. J Biol Chem 1996, 271:24874-24879.
49. Asea A, Kraeft SK, Kurt-Jones EA, et al.: Hsp7O stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nature Med 2000, 6:435-442.
50. Asea A, Rehl M, Kabingu E, et al.: Novel signal transduction pathway utilized by extracellular hsp70. Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002, 277: 5028-15034.
51. Milner CM, Campbell RD: Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 1990, 32: 42-251.
52. Goldenberg RL, Klebanoff MA, Nugent R, et al.: Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1996, 174:1618-1621.
53. Royce RA, Jackson TP, Thorp JM, et al.: Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis 1999, 26:96-102.
54. Stevens-Simon C, Jamison J, McGregor JA, Douglas JM: Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis 1994, 21:168-172.